Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,138 | -5,339 | -3,280 | -13,003 | -7,503 |
| Depreciation Amortization | -127 | 34 | 26 | 1,204 | 1,122 |
| Accounts receivable | -1,585 | 52 | -229 | -775 | -1,064 |
| Other Working Capital | -208 | -85 | -770 | -1,422 | -1,532 |
| Other Operating Activity | 3,167 | 379 | 445 | 7,110 | 4,117 |
| Operating Cash Flow | $-6,891 | $-4,959 | $-3,808 | $-6,886 | $-4,860 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,239 | 3,214 | 1,873 | 11,185 | 13,655 |
| PPE Investments | -1,013 | -568 | -314 | 8,976 | -940 |
| Net Acquisitions | -644 | -344 | -46 | -2,896 | N/A |
| Other Investing Activity | 8 | 46 | 0 | 0 | -1,478 |
| Investing Cash Flow | $3,590 | $2,348 | $1,513 | $17,265 | $11,237 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 490 | N/A | N/A | N/A | N/A |
| Debt Repayment | -275 | -173 | -72 | -1,422 | -504 |
| Common Stock Issued | 575 | -238 | -198 | 893 | 13 |
| Common Stock Repurchased | -248 | 2 | N/A | -7,442 | -4,284 |
| Financing Cash Flow | $542 | $-409 | $-270 | $-7,971 | $-4,775 |
| Beginning Cash Position | 5,108 | 5,108 | 5,108 | 2,700 | 2,700 |
| End Cash Position | 2,349 | 2,088 | 2,543 | 5,108 | 4,302 |
| Net Cash Flow | $-2,759 | $-3,020 | $-2,565 | $2,408 | $1,602 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,891 | -4,959 | -3,808 | -6,886 | -4,860 |
| Capital Expenditure | -1,013 | -531 | -287 | -909 | -875 |
| Free Cash Flow | -7,904 | -5,490 | -4,095 | -7,795 | -5,735 |